Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Current Deferred Revenue (2021 - 2024)

Intelligent Bio Solutions has reported Current Deferred Revenue over the past 4 years, most recently at $2.3 million for Q1 2024.

  • Quarterly results put Current Deferred Revenue at $2.3 million for Q1 2024, up 109.36% from a year ago — trailing twelve months through Mar 2024 was $2.3 million (up 109.36% YoY), and the annual figure for FY2023 was $2.3 million, down 17.57%.
  • Current Deferred Revenue for Q1 2024 was $2.3 million at Intelligent Bio Solutions, down from $2.4 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for INBS hit a ceiling of $4.7 million in Q2 2021 and a floor of $60413.0 in Q3 2022.
  • Median Current Deferred Revenue over the past 4 years was $2.3 million (2023), compared with a mean of $2.4 million.
  • Biggest five-year swings in Current Deferred Revenue: crashed 96.7% in 2022 and later soared 3609.35% in 2023.
  • Intelligent Bio Solutions' Current Deferred Revenue stood at $3.4 million in 2021, then plummeted by 37.08% to $2.2 million in 2022, then grew by 12.95% to $2.4 million in 2023, then decreased by 5.89% to $2.3 million in 2024.
  • The last three reported values for Current Deferred Revenue were $2.3 million (Q1 2024), $2.4 million (Q4 2023), and $2.2 million (Q3 2023) per Business Quant data.